Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target: Trends in Pharmacological Sciences
Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target: Trends in Pharmacological Sciences
Lysosomal Acid Lipase in Lipid Metabolism and Beyond | Arteriosclerosis, Thrombosis, and Vascular Biology
Lysosomal Acid Lipase Deficiency: Presentation, Diagnosis, and Treatment (Transcript)
Lysosomal acid lipase deficiency - early diagnosis is the key. - Abstract - Europe PMC
Lysosomal acid lipase deficiency – early diagnosis is the key | HMER
Alexion Pharmaceuticals - Lysosomal Acid Lipase Deficiency (#LALD) is a rare, inherited, progressive condition in which people have an uncontrolled buildup of fatty material in their liver & other organs. Learn more:
Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation - ScienceDirect
Typical findings and differential diagnoses of lysosomal acid lipase... | Download Table
Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies. - Abstract - Europe PMC
Therapy for lysosomal acid lipase deficiency: Replacing a missing link - Grabowski - 2013 - Hepatology - Wiley Online Library
Manifestations of Lysosomal Acid Lipase Deficiency (LAL-D)
Lysosomal Acid Lipase Deficiency | SpringerLink
Lysosomal Acid Lipase Deficiency — A New Therapy for a Genetic Lipid Disease | NEJM